Yang WT - Search Results

1

Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria.

Xie XQ, Yang Y, Wang Q, Liu HF, Fang XY, Li CL, Jiang YZ, Wang S, Zhao HY, Miao JY, Ding SS, Liu XD, Yao XH, Yang WT, Jiang J, Shao ZM, Jin G, Bian XW. Xie XQ, et al. Among authors: yang wt, yang y. Cell Res. 2023 Mar;33(3):215-228. doi: 10.1038/s41422-022-00766-z. Epub 2023 Jan 10. Cell Res. 2023. PMID: 36627348 Free PMC article.

2

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial.

Huang L, Chen S, Yang W, Xu B, Huang T, Yang H, Zheng H, Wang Y, Song E, Zhang J, Cui S, Pang D, Tang L, Lei Y, Geng C, Shao Z. Huang L, et al. Oncotarget. 2015 Jul 30;6(21):18683-92. doi: 10.18632/oncotarget.4337. Oncotarget. 2015. PMID: 26084292 Free PMC article. Clinical Trial.

3

Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.

Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian XW, Yang W, Zhang J, Yemelyanova A, Malpica A, Zhang Z, Fuller GN, Liu J. Liang L, et al. Am J Surg Pathol. 2016 Jun;40(6):847-56. doi: 10.1097/PAS.0000000000000635. Am J Surg Pathol. 2016. PMID: 26990854 Free PMC article.

4

Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.

Ji G, Bao L, Yao Q, Zhang J, Zhu X, Bai Q, Shao Z, Yang W, Zhou X. Ji G, et al. J Cancer Res Clin Oncol. 2021 Oct;147(10):2935-2944. doi: 10.1007/s00432-021-03696-2. Epub 2021 Jul 13. J Cancer Res Clin Oncol. 2021. PMID: 34254208

5

Genomic alterations affecting tumor-infiltrating lymphocytes and PD-L1 expression patterns in triple-negative breast cancer.

Wang H, Ding XH, Liu CL, Xiao Y, Shui RH, Li YP, Chen C, Yang WT, Liu S, Chen CS, Shao ZM, Jiang YZ. Wang H, et al. Among authors: yang wt. J Natl Cancer Inst. 2023 Dec 6;115(12):1586-1596. doi: 10.1093/jnci/djad154. J Natl Cancer Inst. 2023. PMID: 37549066

6

Molecular features and clinical implications of the heterogeneity in Chinese patients with HER2-low breast cancer.

Dai LJ, Ma D, Xu YZ, Li M, Li YW, Xiao Y, Jin X, Wu SY, Zhao YX, Wang H, Yang WT, Jiang YZ, Shao ZM. Dai LJ, et al. Among authors: yang wt. Nat Commun. 2023 Aug 22;14(1):5112. doi: 10.1038/s41467-023-40715-x. Nat Commun. 2023. PMID: 37607916 Free PMC article.

7

Single-cell morphological and topological atlas reveals the ecosystem diversity of human breast cancer.

Zhao S, Chen DP, Fu T, Yang JC, Ma D, Zhu XZ, Wang XX, Jiao YP, Jin X, Xiao Y, Xiao WX, Zhang HY, Lv H, Madabhushi A, Yang WT, Jiang YZ, Xu J, Shao ZM. Zhao S, et al. Among authors: yang wt, yang jc. Nat Commun. 2023 Oct 25;14(1):6796. doi: 10.1038/s41467-023-42504-y. Nat Commun. 2023. PMID: 37880211 Free PMC article.

8

Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.

Zhao YY, Ge HJ, Yang WT, Shao ZM, Hao S. Zhao YY, et al. Among authors: yang wt. Breast Cancer Res Treat. 2024 Feb;203(3):543-551. doi: 10.1007/s10549-023-07153-1. Epub 2023 Oct 28. Breast Cancer Res Treat. 2024. PMID: 37897648

9

HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis.

Lin M, Luo T, Jin Y, Zhong X, Zheng D, Zeng C, Guo Q, Wu J, Shao ZM, Hu X, Yang W, Zhang J. Lin M, et al. Cancer. 2024 Mar 15;130(6):851-862. doi: 10.1002/cncr.35101. Epub 2023 Nov 7. Cancer. 2024. PMID: 37933913

10

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.

Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Among authors: yang wt, yang ys. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

672 results

Search Page

Filters